Author

J. Shukla

Observed name: Jainish Shukla

Institutions: Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research

Observed institutions: Homerton University Hospital, Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research, Post Graduate Institute of Medical Education and Research

ORCID: 0009-0003-9920-562X

Observed ORCID: 0009-0003-9920-562X

OpenAlex ID: A5012470475

BCG and infection with Mycobacterium tuberculosis

2014 · R. D. Turner, C. D. Tweed, et al. · Thorax · 4

28P Development 68Ga trastuzumab Fab and bioevaluation by PET imaging in HER2/neu-expressing breast cancer patients

2022 · Y. Rathore, J. Shukla, et al. · Annals of Oncology · 2

18 F-FDG PET/CT in diagnosis and response evaluation in an unusual case of antisynthetase syndrome presenting as pyrexia of unknown origin

2016 · T.K. Jain, R.K. Basher, et al. · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) · 2

40P Development of radiolabelled plerixafor as a theranostic molecule for targeting CXCR4 receptor expressing cancers: A translational study

2023 · T. Lakhanpal, B.R. Mittal, et al. · ESMO Open · 1

35P Exploring plerixafor as a vector molecule in nuclear medicine for targeting CXCR4 receptor overexpression in vivo

2022 · T. Lakhanpal, J. Shukla, et al. · Annals of Oncology · 1

Aberrant antigen expression in children with acute lymphoblastic leukemia

2025 · Likhitha Bhukaya, Jainish Shukla, et al. · Pediatric Hematology Oncology Journal

636P Development of radiolabelled plerixafor as a theranostic tool for malignant lymphomas

2022 · T. Lakhanpal, J. Shukla, et al. · Annals of Oncology

Works count: 7

Citation count: 10

H-index: 2

I10-index: